Gene · 53353
Papers2,235
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,235
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions. | MedComm (2020) | 2023 | 37719443 | PubTator, text mining | PubMed |
| Osteosarcoma's genetic landscape painted by genes' mutations. | Acta Biochim Pol | 2023 | 37717265 | PubTator, text mining | PubMed |
| Interaction between genetic susceptibility to obesity and food intake on BMI in Finnish school-aged children. | Sci Rep | 2023 | 37709841 | PubTator, text mining | PubMed |
| Whole Exome Analysis to Select Targeted Therapies for Patients with Metastatic Breast Cancer - A Feasibility Study. | Geburtshilfe Frauenheilkd | 2023 | 37706056 | PubTator, text mining | PubMed |
| Immune-active tumor-adjacent tissues are associated with favorable prognosis in stage I lung squamous cell carcinoma. | iScience | 2023 | 37694148 | PubTator, text mining | PubMed |
| Machine learning-identified stemness features and constructed stemness-related subtype with prognosis, chemotherapy, and immunotherapy responses for non-small cell lung cancer patients. | Stem Cell Res Ther | 2023 | 37674202 | PubTator, text mining | PubMed |
| Effective TME-related signature to predict prognosis of patients with head and neck squamous cell carcinoma. | Front Mol Biosci | 2023 | 37670814 | PubTator, text mining | PubMed |
| The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer. | Nat Commun | 2023 | 37666855 | PubTator, text mining | PubMed |
| Analysis of genomic alterations in primary central nervous system lymphoma. | Medicine (Baltimore) | 2023 | 37657032 | PubTator, text mining | PubMed |
| Impact of programmed death-ligand 1 (PD-L1) positivity on clinical and molecular features of patients with metastatic gastric cancer. | Cancer Med | 2023 | 37654198 | PubTator, text mining | PubMed |
| Clinical significance of genetic profiling based on different anatomic sites in patients with mucosal melanoma who received or did not receive immune checkpoint inhibitors. | Cancer Cell Int | 2023 | 37649078 | PubTator, text mining | PubMed |
Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP/SH lymphoma workshop. | Virchows Arch | 2023 | 37646869 | PubTator, text mining | PubMed |
| Barcoded multiple displacement amplification for high coverage sequencing in spatial genomics. | Nat Commun | 2023 | 37644058 | PubTator, text mining | PubMed |
| Prediction model of clinical prognosis and immunotherapy efficacy of gastric cancer based on level of expression of cuproptosis-related genes. | Heliyon | 2023 | 37636385 | PubTator, text mining | PubMed |
| Immune regulation in gastric adenocarcinoma is linked with therapeutic efficacy and improved recovery. | Front Genet | 2023 | 37636266 | PubTator, text mining | PubMed |
| Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer. | Genome Biol | 2023 | 37635261 | PubTator, text mining | PubMed |
| SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma. | Aging (Albany NY) | 2023 | 37632835 | PubTator, text mining | PubMed |
| Utilizing Proteomic Approaches to Uncover the Neuroprotective Effects of ACE Inhibitors: Implications for Alzheimer's Disease Treatment. | Molecules | 2023 | 37630190 | PubTator, text mining | PubMed |
| Construction and Validation of a Reliable Disulfidptosis-Related LncRNAs Signature of the Subtype, Prognostic, and Immune Landscape in Colon Cancer. | Int J Mol Sci | 2023 | 37629096 | PubTator, text mining | PubMed |
| The Proteome Profile of Olfactory Ecto-Mesenchymal Stem Cells-Derived from Patients with Familial Alzheimer's Disease Reveals New Insights for AD Study. | Int J Mol Sci | 2023 | 37628788 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53353/papers?page=15